Effect on Mortality of Higher Versus Lower β-Blocker (Metoprolol Succinate or Carvedilol) Dose in Patients With Heart Failure
- 1 September 2018
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 122 (6) , 994-998
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association (17MCPRP33460225)
- NIH (5T32HL007101)
This publication has 19 references indexed in Scilit:
- Effect of carvedilol vs metoprolol succinate on mortality in heart failure with reduced ejection fractionAmerican Heart Journal, 2018
- 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2016
- The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practiceHeart Failure Reviews, 2016
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic DysfunctionJACC: Heart Failure, 2016
- 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2013
- Treatment of Chronic Heart Failure With β-Adrenergic Receptor AntagonistsCirculation Research, 2011
- Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart FailureAnnals of Internal Medicine, 2009
- Analysis of Randomized Controlled Trials on the Effect of Magnitude of Heart Rate Reduction on Clinical Outcomes in Patients With Systolic Chronic Heart Failure Receiving Beta-BlockersThe American Journal of Cardiology, 2008
- Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trialEuropean Heart Journal, 2005